Hims & Hers Health, INC Form 4 insider transactions

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 10, 2025, according to a Form 4 filing.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 2, 2025, according to a Form 4 filing with the SEC.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports exercising stock options to acquire Class A Common Stock.

Hims & Hers Health, Inc. CFO, Oluyemi Okupe, sold 4,213 shares of Class A Common Stock at an average price of $29.9829 per share on December 26, 2024, under a pre-arranged 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. on December 24, 2024, according to a Form 4 filing.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CFO Oluyemi Okupe sold shares of Class A Common Stock on December 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers CEO Andrew Dudum amended a previous SEC filing to accurately reflect his share transactions and holdings, including sales, acquisitions, and indirect ownership through various trusts.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed multiple transactions involving Class A Common Stock and Restricted Stock Units, including acquisitions, disposals, and tax withholdings.

Director David B. Wells of Hims & Hers Health, Inc. acquired 10,046 shares of Class A Common Stock and vested in 10,046 Restricted Stock Units on December 13, 2024.

Irene Becklund, a Principal Accounting Officer at Hims & Hers Health, Inc., reported multiple transactions involving Class A Common Stock and Restricted Stock Units.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, reported the acquisition of 12,988 shares and the disposal of 5,387 shares to cover tax obligations related to vesting of restricted stock units.

Hims & Hers Health's Chief Legal Officer, Soleil Boughton, reported the acquisition of 43,209 shares and the disposal of 23,751 shares of Class A Common Stock on December 13, 2024, along with the vesting of multiple Restricted Stock Units.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reports the acquisition and disposal of company stock and restricted stock units on December 13, 2024.

Chief Operating Officer of Hims & Hers Health, Melissa Baird, reports the acquisition and disposal of company stock and restricted stock units.

Hims & Hers CEO Andrew Dudum executed multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

A Hims & Hers Health executive exercised stock options and sold shares under a pre-arranged trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares on December 10, 2024, according to a recent SEC filing.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold a portion of the acquired shares on December 2, 2024, under a pre-arranged trading plan.

Hims & Hers CEO Andrew Dudum sold 33,513 shares of Class A Common Stock and transferred shares between various trusts, according to a recent SEC filing.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, sold 2,343 shares of Class A Common Stock at $29.9 per share on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

Hims & Hers Chief Financial Officer, Oluyemi Okupe, exercised stock options and sold shares of Class A Common Stock on November 25, 2024, under a pre-arranged 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares on November 25, 2024, according to a recent SEC filing.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares on November 19, 2024, according to a recent SEC filing.

Director Deborah M. Autor of Hims & Hers Health, Inc. was granted restricted stock units (RSUs) on November 15, 2024, which will vest over the next three years and at the 2025 annual meeting.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold a portion of her holdings on November 18, 2024, according to a recent SEC filing.

A Hims & Hers Health executive, Irene Becklund, exercised stock options and sold shares on November 18, 2024, according to a recent SEC filing.

Director Manuel Anja of Hims & Hers Health, Inc. purchased 5,000 shares of Class A Common Stock in two separate transactions.